Search results
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 22 hours agoThe senior author Rachael Bashford-Rogers is a co-founder of Alchemab and the paper was a collaboration between the Cancer Dynamics Group at The Institute of Cancer...
Dupixent set for FDA review in adolescent chronic inflammatory sinus disease
Pharmaceutical Technology via Yahoo Finance· 2 days agoRegeneron and Sanofi could soon be adding another indication to its blockbuster immunology drug...
Mutations protected mice from B-cell cancers | Newswise
Newswise· 1 day ago“We used a purely genetic method to find a drug target, and that target turns out to be sensational...
Earnings call: Nektar Therapeutics optimistic on REZPEG and pipeline progress By Investing.com
Investing.com· 5 days agoNektar Therapeutics (NASDAQ:NKTR) reported a productive first quarter of 2024, focusing on their ...
Japan's Takeda Pharma Outlines $900M Overhaul To Boost Growth, As 2023 Profit Fall Over 50%
Benzinga· 5 days agoTakeda said it will incur restructuring costs of about 140 billion yen in fiscal year 2024 as part...
Story from Argenx: “Untold Stories” Podcast Shares Powerful Tales of Strength and Perseverance Amid...
USA Today· 13 hours agoPeople living with severe autoimmune disorders often feel unseen and unheard, either because others...
Systemic antibiotics in first year of life tied to higher atopic dermatitis risk
Medical Xpress· 6 days agoCourtney Hoskinson, from the University of British Columbia in Vancouver, Canada, and colleagues...
Nektar Therapeutics (NKTR) First Quarter 2024 Earnings Overview
Guru Focus· 4 days agoThe biopharmaceutical company, known for its innovative approach in immunology and oncology, reported a net loss of $36.8 million, or $0.19 per share, aligning with analyst ...
7 Surprising Asthma Triggers to Know About
GQ via Yahoo News· 5 days ago“Viral infections, allergen exposure, and exposure to irritants and poor air quality are the most common triggers of asthma exacerbation,” says Jeffrey...
Sanofi boosts French biomanufacturing with €1 billion investment By Investing.com
Investing.com· 2 days agoSanofi (EPA:SASY) (NASDAQ:SNY), a global biopharmaceutical company, announced today a significant...